GeneDx Holdings (WGS) Operating Leases: 2022-2025
Historic Operating Leases for GeneDx Holdings (WGS) over the last 4 years, with Sep 2025 value amounting to $57.2 million.
- GeneDx Holdings' Operating Leases fell 5.33% to $57.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $57.2 million, marking a year-over-year decrease of 5.33%. This contributed to the annual value of $60.9 million for FY2024, which is 8.51% down from last year.
- Per GeneDx Holdings' latest filing, its Operating Leases stood at $57.2 million for Q3 2025, which was down 4.14% from $59.6 million recorded in Q2 2025.
- GeneDx Holdings' Operating Leases' 5-year high stood at $69.1 million during Q2 2023, with a 5-year trough of $57.2 million in Q3 2025.
- Over the past 3 years, GeneDx Holdings' median Operating Leases value was $60.9 million (recorded in 2024), while the average stood at $62.7 million.
- In the last 5 years, GeneDx Holdings' Operating Leases increased by 8.93% in 2023 and then fell by 12.00% in 2024.
- GeneDx Holdings' Operating Leases (Quarterly) stood at $66.1 million in 2022, then climbed by 0.68% to $66.6 million in 2023, then dropped by 8.51% to $60.9 million in 2024, then declined by 5.33% to $57.2 million in 2025.
- Its Operating Leases stands at $57.2 million for Q3 2025, versus $59.6 million for Q2 2025 and $59.9 million for Q1 2025.